Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹25,436.8
₹54,051 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,422.7
₹42,762 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,525.8
₹28,866 Cr
Pharmaceuticals & Drugs
₹823.6
₹16,188 Cr
Pharmaceuticals & Drugs
₹1,156.1
₹14,189 Cr
Pharmaceuticals & Drugs
₹623.1
₹9,807 Cr
Pharmaceuticals & Drugs
₹681.2
₹6,177 Cr
Pharmaceuticals & Drugs
₹377.9
₹3,449 Cr
Pharmaceuticals & Drugs
₹308.0
₹3,449 Cr
Pharmaceuticals & Drugs
₹700.9
₹400 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹823.6
₹7,345 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,422.7
₹5,453 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹623.1
₹4,359 Cr
Pharmaceuticals & Drugs
₹377.9
₹2,565 Cr
Pharmaceuticals & Drugs
₹681.2
₹1,819 Cr
Pharmaceuticals & Drugs
₹3,525.8
₹1,339 Cr
Pharmaceuticals & Drugs
₹308.0
₹746 Cr
Pharmaceuticals & Drugs
₹25,436.8
₹6,929 Cr
Pharmaceuticals & Drugs
₹700.9
₹334 Cr
Pharmaceuticals & Drugs
₹1,156.1
₹2,552 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,422.7
₹1,056 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹823.6
₹671 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,525.8
₹356 Cr
Pharmaceuticals & Drugs
₹623.1
₹256 Cr
Pharmaceuticals & Drugs
₹377.9
₹195 Cr
Pharmaceuticals & Drugs
₹681.2
₹179 Cr
Pharmaceuticals & Drugs
₹308.0
₹174 Cr
Pharmaceuticals & Drugs
₹25,436.8
₹1,552 Cr
Pharmaceuticals & Drugs
₹700.9
₹-1 Cr
Pharmaceuticals & Drugs
₹1,156.1
₹564 Cr

You may also like the below Video Courses